Scientist 3, In Vivo Translational Imaging
Roche
Summary
In the Department of Translational Imaging, you will drive preclinical and translational imaging research to help deliver life-changing healthcare solutions. You will work within a highly collaborative, multidisciplinary environment, moving seamlessly between in vivo experimentation, scanner operations (preclinical MRI/PET), quantitative analysis, and modern AI-enabled computational workflows to translate imaging data into therapeutic discoveries.
Job description
The Opportunity
In the Department of Translational Imaging, you will drive preclinical and translational imaging research to help deliver life-changing healthcare solutions. You will work within a highly collaborative, multidisciplinary environment, moving seamlessly between in vivo experimentation, scanner operations (preclinical MRI/PET), quantitative analysis, and modern AI-enabled computational workflows to translate imaging data into therapeutic discoveries.
Key Responsibilities
- Design, execute, and optimize in vivo preclinical imaging studies following approved ethical, compliance, and institutional safety standards.
- Operate and refine preclinical MRI protocols, applying quantitative methods to characterize anatomy, microstructure, physiology, and therapeutic treatment responses.
- Support multimodal imaging studies by integrating data across nuclear imaging (PET/SPECT) and biodistribution workflows.
- Develop and maintain robust, reproducible image-processing pipelines for registration, segmentation, quantitative feature extraction, and longitudinal analysis.
- Build scalable, reproducible analysis code primarily in Python, executing workflows across High-Performance Computing (HPC) clusters utilizing containers and GPU acceleration.
- Apply AI tools, prompting techniques, and coding agents to accelerate scientific discovery, streamline analysis prototyping, and enhance code documentation.
- Partner cross-functionally with biologists, pharmacologists, computational biologists, and research leaders to translate multimodal imaging endpoints into actionable scientific decisions.
Who You Are
- You hold an advanced degree (Ph.D. or equivalent combined education and experience) in Biomedical Engineering, Biophysics, Physics, Imaging Science, Computer Science, or a related quantitative discipline.
- You bring practical hands-on experience or demonstrated comfort conducting in vivo model procedures within institutionally regulated research environments.
- You possess strong working knowledge of MRI physics and image formation, including pulse sequences, contrast mechanisms, signal-to-noise optimization, and artifact mitigation.
- You have demonstrated expertise analyzing 3D/4D quantitative imaging data using Python (or equivalent scientific programming) within Linux and version-controlled (Git) environments.
- You have practical fluency leveraging AI-assisted computational tools, LLM prompting, or coding agents to accelerate research and development workflows.
Preferred
- Hands-on experience with preclinical PET or SPECT acquisition, reconstruction, biodistribution analysis, and quantitative multimodal data integration.
- Experience developing or optimizing custom MRI pulse sequences, novel reconstruction algorithms, quantitative imaging biomarkers, and/or contrast-agent dynamics.
- Solid understanding of computer vision, image processing, and machine learning/deep learning methods for biomedical image segmentation, registration, and automated quality control.
- Proven experience working on High-Performance Computing (HPC) clusters with workload managers (such as Slurm), containerization technologies (Docker, Apptainer/Singularity), and GPU acceleration.
- Proficiency in additional scientific programming languages and platforms (e.g., MATLAB, R, C/C++, ITK, 3D Slicer, or equivalent biomedical toolkits).
- Background in drug discovery, translational medicine, or oncology/neuroscience biomarker development, with a track record of bridging imaging metrics to pharmacological mechanism of action.
- Demonstrable scientific curiosity, agility, and comfort navigating seamlessly between hands-on scanner/bench work and dry-lab computational modeling.
Requirements
- Advanced degree (Ph.D. or equivalent combined education and experience) in Biomedical Engineering, Biophysics, Physics, Imaging Science, Computer Science, or a related quantitative discipline.
- Practical hands-on experience or demonstrated comfort conducting in vivo model procedures within institutionally regulated research environments.
- Strong working knowledge of MRI physics and image formation, including pulse sequences, contrast mechanisms, signal-to-noise optimization, and artifact mitigation.
- Demonstrated expertise analyzing 3D/4D quantitative imaging data using Python (or equivalent scientific programming) within Linux and version-controlled (Git) environments.
- Practical fluency leveraging AI-assisted computational tools, LLM prompting, or coding agents to accelerate research and development workflows.
Benefits
- Relocation assistance
- Annual bonus
- Medical, Dental & Vision
- 401(k) Matching
- Paid Time Off
Company overview
Roche is a Swiss multinational healthcare company and a global pioneer in pharmaceuticals and diagnostics, founded in 1896 and headquartered in Basel, Switzerland. As the world's largest biotech company and the fifth-largest pharmaceutical company by revenue, Roche operates through two primary divisions: Pharmaceuticals and Diagnostics. The company is renowned for its leadership in personalized healthcare, combining strengths in both drug development and diagnostic testing to deliver tailored treatments for patients. Roche maintains a strong focus on oncology, immunology, infectious diseases, ophthalmology, and central nervous system disorders, with a portfolio that includes over 30 medicines on the World Health Organization's Model Lists of Essential Medicines. The company owns significant subsidiaries including Genentech, Chugai Pharmaceuticals, Ventana Medical Systems, and Foundation Medicine. With approximately 103,000 employees worldwide and operations in over 100 countries, Roche has established itself as a leader in cancer treatments globally while maintaining a robust pipeline of innovative therapies and diagnostic solutions. The company's commitment to sustainability has been recognized through ten consecutive years as Group Leader in the Dow Jones Sustainability Indices within the Pharmaceuticals, Biotechnology & Life Sciences Industry.